HYSEQ, INC. FORM 8-K

Company

Oruka Therapeutics, Inc.

Filed

November 1, 2002

Period of Report

October 25, 2002

Accession Number

0000891618-02-004836

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →